Delivery Order SPE2DB20D7061-SPE2DB23FSQU4
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,871,380 units of XEOMIN 100 unit vials. The contract has a potential value of $4,718.16 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to provide a comprehensive range of pharmaceuticals and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,937.00, is for the delivery of 4,568,633,260 units of XEOMIN 200 unit vials. The contract is a firm fixed-price delivery order with a completion date of July 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,563,885,161 units of XEOMIN 100 unit vials. The contract has a potential value of $10,713.60 and a completion date of March 27, 2024. This contract is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $3,145.44, is for the supply of 4,565,159,285 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop...
- The U.S. Defense Logistics Agency awarded a $40,082.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,562,991,153 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. This contract has a completion date of September 5, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,158,431 units of XEOMIN 200 unit vials. The contract has a potential value of $3,145.50 and a completion date of January 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has an extensive history of providing pharmaceutical products and medical supplies to support U.S. government...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $3,669.68 for the supply of 4,563,451,766 units of XEOMIN 100 unit vials. The delivery order is set to be completed by February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense through an Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- This is a firm fixed price delivery order worth $1,310.60 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,696,261 vials of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation noted. This delivery order is issued under a larger indefinite delivery contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of XEOMIN 100 unit vials, a pharmaceutical product, with a ceiling value of $31,454.40 and an ultimate completion date of July 19, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB23FSQU4Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,561,991,445 units of XEOMIN 100-unit vials, with a ceiling value of $1,310.60. The contract has a firm fixed price pricing type and an ultimate completion date of September 15, 2023. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a single-award IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, and a smaller IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through May 2024. These contracts enable the government to efficiently procure a wide range of essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/24/23 |